CASE STUDY
See how real-time, remote data collection enabled rapid, agile deployment of an infectious disease trial.
Infectious Disease
Real-Time Data Solutions
Infectious disease studies frequently call for urgent and accelerated trial timelines, and requirements for patient participation and high-quality data are often more stringent. The declaration of a new virus or pandemic requires rapid response to develop and implement highly time-sensitive clinical trials.
Infectious disease trials require careful patient safety monitoring and close collaboration between study teams and regulatory authorities. Identifying and enrolling eligible patients is challenging. Target populations are at high risk for infection, often with compromised immune systems or underlying chronic conditions. Investigating treatments can have significant risks or side effects, be controversial, or raise ethical concerns.
Infectious disease trials require careful patient safety monitoring and close collaboration between study teams and regulatory authorities. Investigating treatments can present significant risks or side effects, be controversial, or raise ethical concerns.
Uninterrupted Real-Time Data Continuity
As COVID-19 spread worldwide, researchers raced to develop effective diagnostics, vaccines, and treatments. Traditional decade-long timelines were reduced to under twelve months, and the FDA granted Emergency Use Authorization in record time.
Drug development during COVID-19 demonstrated the power of clinical trial digital technology. Powering research to stay on track during times of extreme disruption, mobile technology, telehealth, and remote monitoring enable patients to participate in research projects from anywhere.
Access to real-time data captured with Direct Data Capture (DDC) technology, electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Outcome Assessments (eCOA) provide infectious study teams with real-time data collection, analysis, and quality required for immediate insights and interim analysis reporting.
eSource Solutions for Infectious Disease Trials
In evolving infectious disease situations, proven digital technology solutions guarantee your ability to respond quickly to individual or epidemiologic developments.
Gain Uninterrupted, Real-Time Access
Direct Data Capture (DDC) technology, eCOA, and ePRO data enable immediate insights and interim analysis reporting.
Minimize Source Data Verification (SDV)
Enable remote source data review and vastly reduce on-site monitoring.
Deploy Virtual and Hybrid Trials
Facilitate infectious disease research projects anywhere they occur (e.g., in mobile units, ambulatory centers, remote medical tents).
Enable Central Monitoring
Gain quicker oversight and faster response to patient experience and needs. Scale or eliminate in-person interactions using DDC and remote data monitoring.
Collect Data Anywhere
Collect data online or offline in changing environments across multiple forms within a patient’s chart and across different tablets.
Prevent Infection
Enhance safety for patients and clinicians in non-traditional settings with sterilized tablets and styluses and glove-compatible data entry.
Ensure Urgency and Time-Sensitivity
Rapid study build and conduct reveal study outcomes faster.
